Sriram Subramaniam, Gandeeva Therapeutics founder and CEO

Cryo-EM fo­cused biotech from long­time NIH vet­er­an se­cures $40M back­ing from Bay­er in Se­ries A

“It’s al­ways nice to get mon­ey in the bank.”

That’s what Gan­dee­va Ther­a­peu­tics’ founder and CEO Sri­ram Sub­ra­ma­ni­am said af­ter re­veal­ing that his com­pa­ny land­ed $40 mil­lion in Se­ries A fund­ing. Gan­dee­va will use the mon­ey for its ar­ti­fi­cial in­tel­li­gence-en­abled plat­form to iden­ti­fy small mol­e­cules and bi­o­log­ics at a faster pace.

The com­pa­ny is on a mis­sion to show that it can lever­age cryo-EM and AI to make a mean­ing­ful im­pact on drug dis­cov­ery, and it plans to do so with speed, us­ing AI for ex­per­i­ment pre­dic­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.